Source:http://linkedlifedata.com/resource/pubmed/id/15704140
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-4-25
|
pubmed:abstractText |
LAF-4, which encodes a nuclear protein with transactivation potential, is fused to the MLL gene in acute lymphoblastic leukemia (ALL). We identified LAF-4 as a gene that is transcriptionally deregulated in breast tumors and thus may have a pathological role in mammary tumorigenesis. In line with the previous finding that LAF-4 expression is tissue specific, we did not detect any LAF-4 mRNA in normal mammary epithelial cell lines. However, 2 of 5 breast cancer cell lines were found to express LAF-4 at both the RNA and protein levels. In 2 of 9 primary tumor-normal pairs, the expression of LAF-4 was clearly elevated in the tumor tissue. Using RNA in situ hybridization, we demonstrated that LAF-4 is expressed in mammary tumor cells but not in normal acini. In a group of 64 primary human breast tumors, we found that LAF-4 was overexpressed in approximately 20% of the cases. Although epigenetic changes may be involved in altered expression of some genes, differences in LAF-4 expression were not associated with DNA methylation of the predicted promoter region. Our results suggest that LAF-4 may be a proto-oncogene that is transcriptionally activated in some cases of breast cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2005 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
115
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
568-74
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15704140-Breast,
pubmed-meshheading:15704140-Breast Neoplasms,
pubmed-meshheading:15704140-DNA, Neoplasm,
pubmed-meshheading:15704140-DNA Methylation,
pubmed-meshheading:15704140-Female,
pubmed-meshheading:15704140-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15704140-Humans,
pubmed-meshheading:15704140-Menopause,
pubmed-meshheading:15704140-Nuclear Proteins,
pubmed-meshheading:15704140-Promoter Regions, Genetic,
pubmed-meshheading:15704140-RNA, Messenger,
pubmed-meshheading:15704140-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:15704140-Transcription, Genetic,
pubmed-meshheading:15704140-Tumor Cells, Cultured
|
pubmed:year |
2005
|
pubmed:articleTitle |
LAF-4 is aberrantly expressed in human breast cancer.
|
pubmed:affiliation |
Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|